Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 5Phase 4 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 2adacel 2Tetanus Toxoid 2Oxaliplatin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Diphtheria-Tetanus-acellular Pertussis Vaccines 2Diphtheria Toxoid 2testosterone enanthate 1sofosbuvir-velpatasvir drug combination 1pegfilgrastim 1fluarix 1epoetin beta 1arexvy 1abrysvo 1Vincristine 1Thyrotropin Alfa 1Radiotherapy 1Oxycodone 1Morphine 1Levopropoxyphene 1Leucovorin 1Irinotecan 1Influenza Vaccines 1Heplisav-B 1Fluorouracil 1FluLaval 1Filgrastim 1Etanercept 1Epoetin Alfa 1Dutasteride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NIH × Dactinomycin × Clear all
NCT00491946 2007-06-26

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phase 4 Unknown
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡